Compare ANIP & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | KN |
|---|---|---|
| Founded | 2001 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | N/A | N/A |
| Metric | ANIP | KN |
|---|---|---|
| Price | $80.93 | $24.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $107.33 | $22.33 |
| AVG Volume (30 Days) | 532.5K | ★ 631.3K |
| Earning Date | 02-27-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.67 | 0.48 |
| Revenue | ★ $826,880,000.00 | $573,500,000.00 |
| Revenue This Year | $44.35 | $9.26 |
| Revenue Next Year | $11.13 | $5.87 |
| P/E Ratio | ★ $48.56 | $50.67 |
| Revenue Growth | ★ 48.87 | 4.24 |
| 52 Week Low | $54.10 | $12.19 |
| 52 Week High | $99.50 | $25.33 |
| Indicator | ANIP | KN |
|---|---|---|
| Relative Strength Index (RSI) | 43.98 | 57.11 |
| Support Level | $83.03 | $23.73 |
| Resistance Level | $86.97 | $25.33 |
| Average True Range (ATR) | 3.53 | 0.75 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 42.98 | 66.18 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.